Why Africans and Europeans React To Medicines Differently: Zimbabwean Scientist Tests Effectiveness of Pharmacogenetics in African Populations
While some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the
Read More
Why Africans and Europeans React To Medicines Differently: Zimbabwean Scientist Tests Effectiveness of Pharmacogenetics in African Populations
While some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the field
Read More
DTG Won’t Be Forced On Citizens- Ministry
PEOPLE Living With HIV (PLHIV) and on Antiretroviral Therapy (ART) still have the option to continue taking other ART options apart from Dolutogravir (DTG) based regimens  since the process is not compulsory, a ministry of health and child care (MoHCC) official has said. By Michael Gwarisa in Gweru Zimbabwe commenced its transition process from Tenovir/Lamuvidene/Efavirens
Read More
#BREAKING: Zim To Switch To New ARV Drug With Less Side Effects
ZIMBABWE is ready to transition to Teno-Lamuvudine Dolutegrevir (TLD), an Anti-retro Viral (ARV) drug with less side effects, moving away from the Teno-Lamivudine-Efavirenz (TLE) a three in one drug that is taken once a day, a top health official has said By Michael Gwarisa The development comes barely a year after government through the Ministry
Read More